MFWLX
Price
$16.77
Change
+$0.04 (+0.24%)
Updated
May 9 closing price
Net Assets
1.21B
RIREX
Price
$72.60
Change
+$0.12 (+0.17%)
Updated
May 9 closing price
Net Assets
109.59B
Ad is loading...

MFWLX vs RIREX

Header iconMFWLX vs RIREX Comparison
Open Charts MFWLX vs RIREXBanner chart's image
MFS Global Total Return R6
Price$16.77
Change+$0.04 (+0.24%)
VolumeN/A
Net Assets1.21B
American Funds Capital Income Bldr R4
Price$72.60
Change+$0.12 (+0.17%)
VolumeN/A
Net Assets109.59B
MFWLX vs RIREX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MFWLX vs. RIREX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFWLX is a Buy and RIREX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIREX has more cash in the bank: 110B vs. MFWLX (1.21B). RIREX pays higher dividends than MFWLX: RIREX (3.12) vs MFWLX (2.31). MFWLX was incepted earlier than RIREX: MFWLX (13 years) vs RIREX (23 years). MFWLX (0.85) is less costly to investors than RIREX (0.62). MFWLX is a more actively managed with annual turnover of: 69.00 vs. RIREX (56.00). MFWLX has a lower initial minimum investment than RIREX: MFWLX (0) vs RIREX (250). RIREX annual gain was more profitable for investors over the last year : 10.22 vs. MFWLX (-0.55). RIREX return over 5 years is better than : 47.50 vs. MFWLX (10.32).
MFWLXRIREXMFWLX / RIREX
Total Expense Ratio0.770.62124%
Annual Report Gross Expense Ratio0.850.62137%
Fund Existence13 years23 years-
Gain YTD4.6105.97577%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.21B110B1%
Annual Yield % from dividends2.313.1274%
Returns for 1 year-0.5510.22-5%
Returns for 3 years8.8222.3939%
Returns for 5 years10.3247.5022%
Returns for 10 years18.5437.6149%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STVN24.001.52
+6.76%
Stevanato Group SpA
STOK9.360.31
+3.43%
Stoke Therapeutics
AMBP3.730.11
+3.04%
Ardagh Metal Packaging SA
CHSCL25.660.10
+0.39%
CHS
CTMX0.93-0.16
-14.83%
CytomX Therapeutics